CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	May 31, 2026	Aug. 31, 2025
Current assets
Cash	$ 4,789,312	$ 6,555,642
Deferred research and development costs	4,216	30,687
Prepaid expenses and other current assets	46,608	15,836
Total current assets	4,840,136	6,602,165
Property and Equipment, net	60,724	43,089
Total assets	4,900,860	6,645,254
Current liabilities
Accounts payable and accrued expenses	193,987	114,309
Related party payables	112,378	79,866
Total current liabilities	306,365	194,175
Total liabilities	306,365	194,175
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding
Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 shares issued and outstanding at May 31, 2026 and August 31, 2025	65,779	65,779
Additional paid-in capital	87,475,862	87,475,862
Accumulated deficit	(82,947,146)	(81,090,562)
Total stockholders' equity	4,594,495	6,451,079
Total liabilities and stockholders' equity	$ 4,900,860	$ 6,645,254

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.